Earnings Feed
Start Free
Home/Filings/4/0001140361-17-007729
4//SEC Filing

BioRestorative Therapies, Inc. 4

Accession 0001140361-17-007729

$BRTXCIK 0001505497operating
View on SEC.govCompany Profile

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:44 PM ET

Size

20.6 KB

Accession

0001140361-17-007729

Insider Transaction Report

Form 4
Period: 2017-02-14
BioRestorative Therapies, Inc.BRTX
Tonna Paul Jude
Director
Transactions
  • Award

    Option

    2017-02-14+15,000→ 15,000 total
    Exercise: $4.70Exp: 2024-06-27→ Common Stock (15,000 underlying)
  • Award

    Option

    2017-02-14+60,000→ 60,000 total
    Exercise: $4.70Exp: 2025-09-04→ Common Stock (60,000 underlying)
  • Award

    Option

    2017-02-14+25,000→ 25,000 total
    Exercise: $4.70Exp: 2024-10-23→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Option

    2017-02-14−15,000→ 0 total
    Exercise: $5.70Exp: 2024-06-27→ Common Stock (15,000 underlying)
  • Disposition to Issuer

    Option

    2017-02-14−25,000→ 0 total
    Exercise: $6.60Exp: 2024-10-23→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Option

    2017-02-14−60,000→ 0 total
    Exercise: $7.00Exp: 2025-09-04→ Common Stock (60,000 underlying)
Holdings

  • Warrant

    Exercise: $15.00From: 2014-08-01Exp: 2019-07-31→ Common Stock (100 underlying)
    100

  • Common Stock

    6,000

  • Warrant

    Exercise: $15.00From: 2014-08-01Exp: 2019-07-11→ Common Stock (1,400 underlying)
    1,400

  • Option

    Exercise: $3.73Exp: 2026-06-10→ Common Stock (64,000 underlying)
    64,000
Footnotes (6)
  • [F1]Owned jointly with wife.
  • [F2]The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016.
  • [F3]The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017.
  • [F4]The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
  • [F5]The option is exercisable to the extent of 21,334 shares on June 10, 2016, and 21,333 shares on each of June 10, 2017 and June 10, 2018.
  • [F6]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.

Documents

1 file

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

→
Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001505497

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:44 PM ET
Size
20.6 KB
View on SEC.gov